Wikidata

(Q53048468)

English

Cost-effectiveness of liraglutide versus rosiglitazone, both in combination with glimepiride in treatment of type 2 diabetes in the US.

scientific article

In more languages
default for all languages
No label defined

No description defined

Statements

title
Cost-effectiveness of liraglutide versus rosiglitazone, both in combination with glimepiride in treatment of type 2 diabetes in the US. (English)
1 reference
stated in
Europe PubMed Central
PubMed publication ID
21348806
retrieved
10 May 2018
reference URL
http://europepmc.org/abstract/MED/21348806

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    Retrieved from "https://www.wikidata.org/w/index.php?title=Q53048468&oldid=1512261647"